DOI: 10.1055/s-00023610

Drug Research

References

Wu D, Yang XO.
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.

Journal of Microbiology, Immunology and Infection 2020;
53: 368-370

Download Bibliographical Data

Access:
Access: